Please login to the form below

Not currently logged in

BMS appoints Murdo Gordon as chief commercial officer

He also becomes executive vice president

BMS Murdo GordonBristol-Myers Squibb has appointed Murdo Gordon to the newly-created position of executive vice president and chief commercial officer.

In this new role, Gordon will have responsibility for the New York-headquartered firm's global commercial strategy, as well as its new worldwide commercialisation team. He will report directly to BMS' chief executive Giovanni Caforio.

Gordon has nearly 30 years of industry experience with the biopharma company, having first joined its Canadian operations in 1989, where he held positions of increasing responsibility, including vice president of marketing, before moving to the US in 2003.

There he worked in a number of senior commercial leadership posts across the cardiovascular and neuroscience therapeutic areas, as well as in market access.

He was promoted to president of BMS' US operations in 2013, before taking on his most recent role as head of worldwide markets in January last year.

Gordon currently also serves a member of the board of directors for RWJBarnabas Health, a New Jersey-based comprehensive healthcare services provider.

22nd June 2016

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...